Home › Research › Risk factors
Rural‐urban disparities in Alzheimer's Disease and Related Dementia: The role of state‐level nurse practitioner policies
Nasim Ferdows. Alzheimer s & Dementia, 2025-12-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
ADRD mortality rates were slightly higher in rural areas compared to urban areas, with no significant differences between rural-adjacent and rural-nonadjacent counties in recent years. Medicare claims data showed lower ADRD prevalence in rural areas. In contrast, HRS cognitive assessments revealed higher ADRD prevalence in rural areas. Stratification by NP practice authority showed that states with restricted NP practice had lower ADRD prevalence in Medicare claims data, particularly in rural communities. The difference was less pronounced in full-practice states, where NPs have independent authority to diagnose and treat ADRD. Lower ADRD rates in rural Medicare claims data likely reflect limited healthcare access rather than true differences in disease burden. HRS cognitive assessments indicate higher ADRD prevalence in rural areas, suggesting underdiagnosis in claims-based data. Restrictive NP policies further limit access, particularly in rural communities. Expanding NP practice authority could improve ADRD diagnosis and care, reducing rural disparities.
What this study adds
Evidence grade: Low
This study found that Medicare claims data showed lower Alzheimer's disease and related dementias prevalence in rural areas while cognitive assessments showed higher prevalence there, suggesting underdiagnosis in claims data. It also found that states with restricted nurse practitioner practice had lower measured prevalence, and the authors suggest expanding practice authority could improve diagnosis and care, not treat or cure the disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Ferdows, N. (2025). Rural‐urban disparities in Alzheimer's Disease and Related Dementia: The role of state‐level nurse practitioner policies. Alzheimer s & Dementia. https://doi.org/10.1002/alz70860_106204
Vancouver
Ferdows N. Rural‐urban disparities in Alzheimer's Disease and Related Dementia: The role of state‐level nurse practitioner policies. Alzheimer s & Dementia. 2025. doi:10.1002/alz70860_106204. PMID: 41433938.
BibTeX
@article{ferdows2025-41433938,
author = {Ferdows, Nasim},
title = {{Rural‐urban disparities in Alzheimer's Disease and Related Dementia: The role of state‐level nurse practitioner policies}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz70860_106204},
pmid = {41433938},
url = {https://doi.org/10.1002/alz70860_106204}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- ADRD mortality rates were slightly higher in rural areas compared to urban areas, with no significant differences between rural-adjacent and rural-nonadjacent counties in recent years.
- Medicare claims data showed lower ADRD prevalence in rural areas.
- In contrast, HRS cognitive assessments revealed higher ADRD prevalence in rural areas.
- Stratification by NP practice authority showed that states with restricted NP practice had lower ADRD prevalence in Medicare claims data, particularly in rural communities.
- The difference was less pronounced in full-practice states, where NPs have independent authority to diagnose and treat ADRD.
Why it matters
This study found that Medicare claims data showed lower Alzheimer's disease and related dementias prevalence in rural areas while cognitive assessments showed higher prevalence there, suggesting underdiagnosis in claims data. It also found that states with restricted nurse practitioner practice had lower measured prevalence, and the authors suggest expanding practice authority could improve diagnosis and care, not treat or cure the disease.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Evidence strengthLow
How this study scored 30/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Nasim Ferdows: h-index 6 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Northeastern University: institution h-index 706 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41433938) |
| Free to read | 2 / 2 | Free to read |
| Total | 30 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/alz70860_106204
- PubMed: 41433938
- Original source →
- Free full text: Alzheimer s & Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk factors from nearby years
Also tagged “prevalence”
1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.